InfuSystems Holdings Inc
$ 10.34
0.68%
24 Apr - close price
- Market Cap 207,392,000 USD
- Current Price $ 10.34
- High / Low $ 10.40 / 9.97
- Stock P/E 33.13
- Book Value 2.84
- EPS 0.31
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.12 %
- 52 Week High 11.04
- 52 Week Low 4.66
About
InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.
Analyst Target Price
$14.90
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-18 | 2025-11-04 | 2025-08-05 | 2025-05-07 | 2025-03-12 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-07 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0.1 | 0.11 | 0.12 | 0.1016 | 0.0705 | 0.08 | 0.03 | -0.05 | 0.0033 | 0.03 | 0.02 | -0.02 |
| Estimated EPS | 0.07 | 0.08 | 0.06 | -0.03 | 0.06 | 0.06 | 0.04 | 0.02 | 0.02 | 0.03 | 0.0267 | 0.02 |
| Surprise | 0.03 | 0.03 | 0.06 | 0.1316 | 0.0105 | 0.02 | -0.01 | -0.07 | -0.0167 | 0 | -0.0067 | -0.04 |
| Surprise Percentage | 42.8571% | 37.5% | 100% | 438.6667% | 17.5% | 33.3333% | -25% | -350% | -83.5% | 0% | -25.0936% | -200% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.04 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INFU
2026-04-12 14:09:41
This article provides an earnings preview for InfuSystem's Q3 2025 financial results. It indicates that the company will report its earnings on April 29, 2026, and offers analyst estimates for revenue and EPS.
2026-04-12 13:40:38
This article provides an earnings preview for InfuSystem's Q3 2025 results. It highlights the expected report date, the previous quarter's strong performance with an EPS beat and revenue growth, and analysts' consensus on the upcoming quarter's EPS and revenue. Investors will be looking for continued growth and clear guidance on future quarters.
2026-04-10 17:10:02
InfuSystem Holdings, Inc. is holding its annual meeting on May 11, 2026, where shareholders will vote on seven director nominees, executive compensation, an increase to its 2021 Equity Incentive Plan, and the ratification of Grant Thornton as auditor. The proxy statement highlights the company's strong 2025 financial performance with record revenue, net income, and Adjusted EBITDA, driven by growth in wound care and oncology. The company also announced a strategic restructuring of a biomedical services contract for 2026, aiming to improve earnings and cash flow despite a revenue reduction.
2026-04-03 18:39:36
This article provides financial information for InfuSystem Holdings, Inc. under the ticker A0NA9V on the Lang & Schwarz Tradecenter. It specifically mentions "Book value per share" as a key financial metric for the company. The content appears to be a stub or a section of a larger financial data platform.
2026-03-31 05:39:22
InfuSystem (NYSE:INFU) shares dropped 2% midday on Monday to $9.35, with trading volume up 24%. Despite the dip, analysts remain positive, with Roth MKM reiterating a "Buy" rating and raising the price target to $15, contributing to a consensus "Buy" rating with an average target of $15. The medical-technology firm, specializing in infusion pumps and remote patient monitoring, has a market cap of $189 million and 71% institutional ownership.
2026-03-30 19:39:22
This article provides a stock price quote and current price chart for InfuSystem Holdings Inc (INFU) on Capital.com. It details trading conditions for INFU CFD, including spread, overnight funding adjustments, and margin requirements. The company, InfuSystem Holdings, Inc., provides infusion pumps and related medical equipment, with its shares influenced by patient volume, equipment utilization, and growth in oncology and pain management markets.
